These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6148960)

  • 41. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E; Mian MA; Raper C
    Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.
    Pouleur H; Van Mechelen H; Balasim H; Rousseau MF; Charlier AA
    J Cardiovasc Pharmacol; 1984; 6(4):720-6. PubMed ID: 6206332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The electrophysiological effects of intravenous xamoterol in man.
    Bowes RJ; Gautam PC; Graham DR; Harley A
    Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous treatment with terbutaline and theophylline.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis Suppl; 1984; 134():211-8. PubMed ID: 6586482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers.
    Haffner CA; Kendall MJ; Maxwell S; Hughes B
    Br J Clin Pharmacol; 1993 Jan; 35(1):35-9. PubMed ID: 8383517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of xamoterol in failing human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Eur Heart J; 1990 Apr; 11(4):323-7. PubMed ID: 1970536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
    Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
    Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
    Mehlsen J; Trap-Jensen J
    Acta Med Scand; 1986; 219(2):173-7. PubMed ID: 2870611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
    Barnett DB; Lu XY
    Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.
    Leslie PJ; Thompson C; Clarke BF; Ewing DJ
    Clin Auton Res; 1991 Jun; 1(2):119-23. PubMed ID: 1688039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
    Yabana H; Watanabe H; Narita H; Nagao T
    Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline.
    Larsson S; Svedmyr N
    Eur J Clin Pharmacol; 1977 Jul; 11(6):429-33. PubMed ID: 891586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
    Hedner J; Ullman A; Lemne C; Svedmyr N
    Pulm Pharmacol; 1989; 2(3):155-9. PubMed ID: 2577692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen.
    Brodde OE; Petrasch S; Bauch HJ; Daul A; Gnadt M; Oefler D; Michel MC
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):434-9. PubMed ID: 1279289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.